The ROE as of September 2024 (TTM) for Comera Life Sciences Holdings, Inc. (CMRA) is 1.54%

According to Comera Life Sciences Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is 1.54%. This represents a change of 285.91% compared to the average of 399.28% of the last 4 quarters.

Comera Life Sciences Holdings, Inc. (CMRA) Historical ROE (quarterly & annually)

How has CMRA ROE performed in the past?

The mean historical ROE of Comera Life Sciences Holdings, Inc. over the last ten years is -326.10%. The current 1.54% ROE has changed -572.51% with respect to the historical average. Over the past ten years (40 quarters), CMRA's ROE was at its highest in in the March 2023 quarter at 1.48%. The ROE was at its lowest in in the March 2021 quarter at -351.12%.

Comera Life Sciences Holdings, Inc. (CMRA) ROE by Quarter and Year

Discovering the peaks and valleys of Comera Life Sciences Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Comera Life Sciences Holdings, Inc. (CMRA) Average ROE

How has CMRA ROE performed in the past?

The current ROE of Comera Life Sciences Holdings, Inc. (CMRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Comera Life Sciences Holdings, Inc. (CMRA) ROE vs. Peers

How is CMRA’s ROE compared to its peers?

Comera Life Sciences Holdings, Inc.’s ROE is greater than SAB Biotherapeutics, Inc. (-94.04%), greater than Processa Pharmaceuticals, Inc. (-151.10%), greater than Fresh Tracks Therapeutics, Inc. (-58.16%), greater than Third Harmonic Bio, Inc. (-6.80%), greater than Indaptus Therapeutics, Inc. (-146.70%), greater than Rezolute, Inc. (-60.90%), greater than Tempest Therapeutics, Inc. (-201.10%), greater than Forte Biosciences, Inc. (-117.85%), greater than Genelux Corporation (-110.28%), greater than Dyadic International, Inc. (-145.95%), less than Cingulate Inc. (11.47%), greater than Monopar Therapeutics Inc. (-110.60%), greater than Shattuck Labs, Inc. (-68.65%), greater than C4 Therapeutics, Inc. (-44.60%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than Prelude Therapeutics Incorporated (-59.82%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Virax Biolabs Group Limited (-115.10%), greater than Blue Water Vaccines, Inc. (-111.44%), greater than Revelation Biosciences, Inc. (-243.91%), greater than Hillstream BioPharma, Inc. (-47249.59%), less than Kiora Pharmaceuticals, Inc. (15.57%),

Build a custom stock screener for Comera Life Sciences Holdings, Inc. (CMRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Comera Life Sciences Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Comera Life Sciences Holdings, Inc. (CMRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Comera Life Sciences Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.